1.26
1.56%
-0.02
Coherus Biosciences Inc Stock (CHRS) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
15.80%
77.06
|
91.52 | 74.57 | 58.72 | 32.44 |
Cost Of Revenue |
59.10%
34.59
|
84.57 | 32.70 | 24.85 | 16.87 |
Gross Profit |
510.56%
42.48
|
6.957 | 41.87 | 33.87 | 15.56 |
Operating Expenses
|
12.05%
85.00
|
75.86 | 73.87 | 68.41 | 83.31 |
Interest Income/Expense |
4.68%
11.12
|
10.62 | 10.27 | 9.943 | 9.712 |
Benefits Costs and Expenses |
115.08%
-25.81
|
171.18 | 114.59 | 101.58 | 108.17 |
Costs And Expenses |
25.46%
119.59
|
160.43 | 106.57 | 93.26 | 100.18 |
Depreciation and Amortization |
41.77%
1.507
|
1.063 | 0.899 | 0.88 | 0.949 |
Operating Income/Loss |
38.28%
-42.52
|
-68.91 | -32.01 | -34.54 | -67.75 |
Income/Loss From Continuing Operations Before Tax |
229.15%
102.88
|
-79.65 | -40.02 | -42.87 | -75.73 |
Income/Loss From Continuing Operations After Tax |
229.15%
102.88
|
-79.65 | -39.64 | -42.87 | -75.73 |
Net Income/Loss
|
229.15%
102.88
|
-79.65 | -39.64 | -42.87 | -75.73 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,816%
112.75
|
5.8847 | 97.74 | 87.27 | 79.27 |
Diluted Average Shares |
2,033%
125.53
|
5.8847 | 97.74 | 87.27 | 79.27 |
Basic Earnings Per Share |
222.97%
0.91
|
-0.74 | -0.41 | -0.49 | -0.96 |
Diluted Earnings Per Share |
212.16%
0.83
|
-0.74 | -0.41 | -0.49 | -0.96 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):